Gujarat Inject Kerala Secures ₹144.9 Million Solar Module Order

MUMBAI — Gujarat Inject (Kerala) Limited (BSE: 524238) has officially secured a major domestic purchase order valued at ₹144.9 million (₹14.49 crore). The contract, awarded by Deon Energy Limited, mandates the supply of high-capacity solar photovoltaic (PV) modules.

Announced following a regulatory filing submitted to the stock exchange, the multi-million rupee transaction marks an essential milestone in the company’s strategic transformation. Once known primarily for manufacturing medical distribution equipment and pharmaceutical formulations, the company is rapidly positioning itself as an active participant in India’s expanding commercial and industrial clean energy supply chain.

Technical Specifications and Execution Timeline

According to compliance documents released by the firm under regulatory guidelines, the procurement order consists of a fixed volume of high-efficiency solar infrastructure components:

• Total Component Count: 16,129 units of premium solar panels.

• Module Capacity: Rated at 620 Wp (Watt-peak) per unit, aligning with modern industrial micro-grid requirements.

• Contract Value: Exactly ₹14,49,00,000 (excluding applicable Goods and Services Tax).

• Execution Deadline: Scheduled for complete delivery within the month of June 2026.

The management clarified that the contract represents an arm's length transaction with a domestic enterprise. Neither the promoter group nor associated boardroom members maintain any financial interest in Deon Energy Limited, ensuring that the agreement bypasses related-party regulatory filters.

Strategic Shift Drives Fiscal and Shareholder Growth

The arrival of the ₹14.49 crore contract follows a separate, smaller ₹1.07 crore solar equipment win from Ottire Lifestyle Private Limited earlier this month. Together, these dual order inflows provide robust short-term revenue visibility for the company's emerging clean energy division.

Financial data from the company's latest audited cycles highlights the scale of this operational transition. Gujarat Inject Kerala reported an impressive 91% year-on-year surge in total revenue to ₹36.32 crore for the fiscal year ending March 2026, accompanied by a 78% rise in net profits. Analysts attribute this financial acceleration directly to the high-margin nature of industrial solar PV distribution compared to competitive generic medical hardware markets.

Stock bourses reacted strongly to the company’s structural news pipeline. Shares of Gujarat Inject Kerala moved sharply higher on the BSE, frequently triggering positive 5% circuit limit caps to settle near an all-time high zone of ₹120 per share.

Official Sources Section

The corporate financials, physical module quantities, and contract execution deadlines detailed in this report are sourced explicitly from the official statutory disclosures filed by Gujarat Inject (Kerala) Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Macro industrial demand targets are aligned with clean energy manufacturing updates tracked by the Ministry of New and Renewable Energy (MNRE).

Quote Section

"According to officials outlining the corporate strategy in exchange filings, the successful onboarding of institutional clients like Deon Energy provides the operational momentum needed to expand the assembly line capabilities of high-output 620 Wp solar modules moving into the next fiscal quarter."

Why It Matters

For commercial power developers and industrial businesses, the availability of locally sourced, verified 620 Wp solar components is vital to mitigating the import cost hikes and supply chain delays that frequently impact large solar arrays. For retail and public equity investors, Gujarat Inject Kerala's successful pivot proves that traditional small-cap companies can successfully transition into high-growth green tech sectors. By securing immediate cash-flow contracts with short-duration execution windows, the company protects its balance sheet from inventory oversupply risks while building long-term domain authority.

Key Facts at a Glance

• Total Order Value: Valued at ₹144.9 million (₹14.49 crore), excluding GST.

• The Blueprint: Supply of 16,129 units of advanced 620 Wp solar photovoltaic panels.

• The Client: Awarded by Deon Energy Limited via a transparent domestic transaction.

• Timeline Constraint: Fast-tracked execution contract required to be fully completed within June 2026.

FAQ Section

1. What are the primary products provided under this new order?

The contract specifies the delivery of 16,129 physical units of high-grade 620 Wp solar PV modules, designed for deployment across institutional and commercial grid installations.

2. Is Gujarat Inject Kerala completely leaving the medical or pharmaceutical sector?

No. While the company is aggressively expanding its presence in the renewable energy market, its foundational manufacturing infrastructure remains equipped to supply intravenous fluids and general medical kits.

3. How does this specific contract affect the company’s near-term earnings?

Because the contract specifies a localized execution target of June 2026, the entire revenue chunk of ₹14.49 crore is expected to be recognized within the first half of the 2026–27 fiscal year, boosting short-term liquidity.

Source:

• BSE Limited Listing Desk

• Gujarat Inject (Kerala) Limited Investor Relations

• Deon Energy Limited